- Home
- FNWB vs SLGL Comparison
FNWB vs SLGL Comparison
Compare FNWB & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNWB
- SLGL
- Stock Information
- Founded
- FNWB 1923
- SLGL 1997
- Country
- FNWB United States
- SLGL Israel
- Employees
- FNWB N/A
- SLGL N/A
- Industry
- FNWB Banks
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- FNWB Finance
- SLGL Health Care
- Exchange
- FNWB Nasdaq
- SLGL Nasdaq
- Market Cap
- FNWB 69.1M
- SLGL 69.1M
- IPO Year
- FNWB 2015
- SLGL 2018
- Fundamental
- Price
- FNWB $8.90
- SLGL $33.50
- Analyst Decision
- FNWB Hold
- SLGL Strong Buy
- Analyst Count
- FNWB 1
- SLGL 1
- Target Price
- FNWB $12.00
- SLGL $50.00
- AVG Volume (30 Days)
- FNWB 12.4K
- SLGL 11.6K
- Earning Date
- FNWB 10-27-2025
- SLGL 11-07-2025
- Dividend Yield
- FNWB 2.32%
- SLGL N/A
- EPS Growth
- FNWB N/A
- SLGL N/A
- EPS
- FNWB N/A
- SLGL N/A
- Revenue
- FNWB $59,854,000.00
- SLGL $23,931,000.00
- Revenue This Year
- FNWB $33.26
- SLGL N/A
- Revenue Next Year
- FNWB $10.68
- SLGL N/A
- P/E Ratio
- FNWB N/A
- SLGL N/A
- Revenue Growth
- FNWB 17.90
- SLGL 264.86
- 52 Week Low
- FNWB $6.05
- SLGL $4.01
- 52 Week High
- FNWB $12.10
- SLGL $52.26
- Technical
- Relative Strength Index (RSI)
- FNWB 63.85
- SLGL 43.78
- Support Level
- FNWB $8.91
- SLGL $34.50
- Resistance Level
- FNWB $9.50
- SLGL $39.00
- Average True Range (ATR)
- FNWB 0.26
- SLGL 3.34
- MACD
- FNWB 0.08
- SLGL -1.26
- Stochastic Oscillator
- FNWB 65.52
- SLGL 20.90
About FNWB First Northwest Bancorp
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.